hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06311539, orgStudyIdInfo id: IstanbulBUFC4, briefTitle: The Effect of Circadian Rhythm on Physical Performance in Healthy Male Individuals, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-01, primaryCompletionDateStruct date: 2024-08-01, completionDateStruct date: 2024-10-01, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Istanbul Bilgi University, class: OTHER, descriptionModule briefSummary: Little is known about optimizing the timing of exercise periods to maximize the health benefits of exercise. Furthermore, exercise is a potent modulator of skeletal muscle metabolism and it is clear that skeletal muscle has a robust circadian profile. Circadian rhythms can be observed in behavior, physiology, and metabolism. Various studies show that exercise changes the rhythm of the clock machines in skeletal muscle. Studies examining the relationship between exercise, especially strength training, and circadian rhythm are quite limited in the literature. Although some studies have shown that force peaks in the afternoon/evening hours, regardless of muscle group and contraction speed, there are no studies on how much this time interval varies from person to person and chronotype.The aim of this study is to investigate to what extent strength training given at appropriate times for morning, evening and intermediate chronotypes creates changes in performance in healthy adult male individuals., conditionsModule conditions: Chronotype, conditions: Exercise, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized Controlled Study, primaryPurpose: SCREENING, maskingInfo masking: SINGLE, maskingDescription: The evaluator who will perform isokinetic assessments and vertical jump measurements will be blinded to the participants' chronotype., whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Theraband Strengthening Exercise Program, outcomesModule primaryOutcomes measure: Isokinetic strength test, primaryOutcomes measure: Vertical jump test, eligibilityModule sex: MALE, minimumAge: 18 Years, maximumAge: 30 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06311513, orgStudyIdInfo id: 2023-1017, secondaryIdInfos id: 1177535, type: OTHER_GRANT, domain: Arthritis Foundation, briefTitle: Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2027-12, completionDateStruct date: 2028-12, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Hospital for Special Surgery, New York, class: OTHER, collaborators name: Emory University, collaborators name: Arthritis Foundation, descriptionModule briefSummary: The goal of this pilot randomized clinical trial is to look into the efficacy of concentrated bone marrow aspirate (cBMA) in improving post traumatic osteoarthritis (PTOA) symptoms in patients undergoing revision anterior cruciate ligament reconstruction surgery. The main questions it aims to answer are whether clinical outcomes, such as pain, are improved in patients who get cBMA with surgery, if there is a change in circulating markers of inflammation and what part of the cellular and molecular composition of cBMA may explain its effects., conditionsModule conditions: Anterior Cruciate Ligament Injuries, conditions: Post-Traumatic Osteoarthritis of Knee, conditions: Bone Marrow Aspirate Concentrate, conditions: ACL Injury, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: This is a single-blinded randomized controlled trial. Participants will be allocated to either:1. Investigational arm (Revision ACLR + cBMA)2. Control arm (Revision ACLR + Sham Incision), primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Concentrated Bone Marrow Aspirate Injection, interventions name: Sham Incision, interventions name: Revision Anterior Cruciate Ligament Reconstruction, outcomesModule primaryOutcomes measure: Change from baseline in patient reported knee pain, secondaryOutcomes measure: Expression of local inflammatory biomarkers, secondaryOutcomes measure: Concentration of circulating inflammatory biomarkers, secondaryOutcomes measure: Change from baseline in cartilage morphology, secondaryOutcomes measure: Change from baseline in articular cartilage relative proteoglycan content and collagen fibril organization, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 55 Years, stdAges: ADULT, contactsLocationsModule locations facility: Emory Orthopaedics & Spine Center, city: Atlanta, state: Georgia, zip: 30097, country: United States, geoPoint lat: 33.749, lon: -84.38798, locations facility: Hospital for Special Surgery, city: New York, state: New York, zip: 10021, country: United States, contacts name: Daniel de la Huerta, MD, role: CONTACT, phone: 212-606-1000, phoneExt: 2603159, email: delahuertamezad@hss.edu, contacts name: Miguel Otero, Ph.D., role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.71427, lon: -74.00597, hasResults: False
protocolSection identificationModule nctId: NCT06311500, orgStudyIdInfo id: STUDY00151143, briefTitle: Sleep Health Enhancement in Midlife Adults, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-13, primaryCompletionDateStruct date: 2025-06-30, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: University of Kansas Medical Center, class: OTHER, descriptionModule briefSummary: Despite the strong links between sleep and AD, a sleep health enhancement has yet to be targeted in mid-life adults (45-64 years old) to delay or prevent AD. An intervention aimed at enhancing sleep health is a critical opportunity for primary prevention to potentially delay the onset of AD. The objective of the proposed study is to develop and assess the feasibility, acceptability, and treatment effect of a comprehensive sleep health intervention (SHI) on improving sleep health in mid-life adults, conditionsModule conditions: Sleep Health, conditions: Midlife Adults, designModule studyType: INTERVENTIONAL, phases: PHASE1, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Sleep health enhancement intervention, outcomesModule primaryOutcomes measure: 6-item Acceptability Scale, primaryOutcomes measure: Qualitative interview, primaryOutcomes measure: Ru-SATED Composite score, primaryOutcomes measure: Sleep Self-Efficacy Scale, primaryOutcomes measure: Pittsburgh Sleep Quality Index, primaryOutcomes measure: Epworth Sleepiness Scale, primaryOutcomes measure: Dysfunctional Beliefs About Sleep (DBAS-10) consists of 10 statements reflecting beliefs and attitudes about sleep. Each statement is rated from 1 = strongly disagree to 10 = strongly agree, primaryOutcomes measure: Positive Affect and Negative Affect Schedule, primaryOutcomes measure: Continuous Performance Test, primaryOutcomes measure: Stroop Test, primaryOutcomes measure: Cognitive Failures Questionnaire, primaryOutcomes measure: Actigraphy, eligibilityModule sex: ALL, minimumAge: 45 Years, maximumAge: 64 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Kansas Medical Center, status: RECRUITING, city: Kansas City, state: Kansas, zip: 66160, country: United States, geoPoint lat: 39.11417, lon: -94.62746, hasResults: False
protocolSection identificationModule nctId: NCT06311487, orgStudyIdInfo id: 23-1388, secondaryIdInfos id: 1R56DK136601-01, type: NIH, link: https://reporter.nih.gov/quickSearch/1R56DK136601-01, briefTitle: Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study), acronym: TANDEM, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-08, completionDateStruct date: 2025-08, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-29, sponsorCollaboratorsModule leadSponsor name: University of Colorado, Denver, class: OTHER, collaborators name: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), descriptionModule briefSummary: This study plans to learn more about metabolic responses to aerobic exercise at different times of the day (morning or evening) under fasting versus fed conditions., conditionsModule conditions: Overweight and Obesity, conditions: Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Fasted-AM, interventions name: Fed-AM, interventions name: Fasted-PM, interventions name: Fed-PM, outcomesModule primaryOutcomes measure: Exercise Energy Expenditure (kcals), primaryOutcomes measure: Substrate Oxidation (Respiratory Quotient), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: University of Colorado Anschutz Medical Campus, city: Aurora, state: Colorado, zip: 80045, country: United States, contacts name: Justin Lorentzen, BHS, role: CONTACT, phone: 303-724-3685, email: justin.lorentzen@cuanschutz.edu, contacts name: Shelby Panter, MS, role: CONTACT, phone: 303-724-3202, email: shelby.panter@cuanschutz.edu, contacts name: Seth Creasy, PhD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 39.72943, lon: -104.83192, hasResults: False
protocolSection identificationModule nctId: NCT06311448, orgStudyIdInfo id: 10094, briefTitle: Personalized Targeted Immunomodulation in COVID-19 ARDS, acronym: COMODULATE, statusModule overallStatus: COMPLETED, startDateStruct date: 2020-03-02, primaryCompletionDateStruct date: 2022-02-01, completionDateStruct date: 2022-02-01, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Erasmus Medical Center, class: OTHER, collaborators name: Amsterdam UMC, collaborators name: Leiden University Medical Center, collaborators name: St. Antonius Hospital, descriptionModule briefSummary: Rationale: In COVID19 single-targeted immunomodulation, mostly via an IL-6 receptor blocker, was used by a one-size fits all non-targeted approach. In future pandemics the same might occur. However, for individual patients, this might not yield optimal treatment.Objectives: This project aims to identify a way to individualize and target immunomodulation, using COVID19 as a testcase for the future.* Identify immunological pathways which are associated with outcome in C-ARDS.* Test whether an individualized biomarker-based approach has an effect on outcome and costs when using single-target immunomodulation in C-ARDS(Tocilizumab, Anakinra, etc.).* Explore whether other immunological pathways were present in patients with C-ARDS which could have been intervened with medication which is already available and has been described in ARDS or similar diseases.Study type: Retrospective observational multicenter study in the Netherlands.Study population: Adult patients (≥ 18 years) hospitalized and admitted to the ICU with COVID-19 and acute respiratory distress syndrome (ARDS) (i.e., receiving invasive mechanical ventilation) will be included.Intervention (if applicable): Not applicable (retrospective study design).Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Given the retrospective nature of the study, no burden, risks or benefits for the patient are associated with participation. The target population of this study is specific to hospitalized patients with COVID-19., conditionsModule conditions: COVID-19 Acute Respiratory Distress Syndrome, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 164, type: ACTUAL, armsInterventionsModule interventions name: Single target immunomodulation, interventions name: Standard of care, outcomesModule primaryOutcomes measure: Mortality up to day 90, primaryOutcomes measure: Change in SOFA score, primaryOutcomes measure: Ventilator free days, primaryOutcomes measure: Change in biomarker values, primaryOutcomes measure: Costs of immmunomodulation, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Erasmus Medical Centre, city: Rotterdam, state: Zuid-Holland, zip: 3015 GD, country: Netherlands, geoPoint lat: 51.9225, lon: 4.47917, hasResults: False
protocolSection identificationModule nctId: NCT06311435, orgStudyIdInfo id: FBB-RNA-004, briefTitle: Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2026-03-15, completionDateStruct date: 2026-03-15, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: MaxWell Clinic, PLC, class: INDUSTRY, descriptionModule briefSummary: The primary objective of this study is to determine, in unblinded samples, whether artificial intelligence can classify specific blood RNA from patients with long COVID together and separately from apparently healthy normals and other medical conditions which share signs and symptoms of long COVID., conditionsModule conditions: Long COVID, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Participants will be placed into one of eleven possible cohorts based on their presenting complaints., primaryPurpose: DIAGNOSTIC, maskingInfo masking: SINGLE, maskingDescription: Patients will be assigned a random number from the electronic health record. The only information shared with the sponsor will be Pt ID number, age, gender and state of residence., whoMasked: PARTICIPANT, enrollmentInfo count: 3000, type: ESTIMATED, armsInterventionsModule interventions name: RNA Biomarker Blood Test, outcomesModule primaryOutcomes measure: Artificial Intelligence Identified number of RNA Biomarkers for Long COVID, secondaryOutcomes measure: Artificial Intelligence Identified number of RNA Biomarkers for specific Long COVID subgroups, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The MaxWell Clinic, status: RECRUITING, city: Brentwood, state: Tennessee, zip: 37027, country: United States, contacts name: Justin Davis, role: CONTACT, phone: 615-370-0091, email: Justin@maxwellclinic.com, contacts name: Cale T Queen, PhD, role: CONTACT, phone: 16153700091, email: cale@maxwellclinic.com, contacts name: David H Haase, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 36.03312, lon: -86.78278, locations facility: The MaxWell Clinic, status: RECRUITING, city: Brentwood, state: Tennessee, zip: 37027, country: United States, contacts name: Justin Davis, role: CONTACT, phone: 615-370-0091, email: justin@maxwellclinic.com, contacts name: Cale T Queen, PhD., role: CONTACT, phone: 6153700091, email: cale@maxwellclinic.com, contacts name: David H Haase, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 36.03312, lon: -86.78278, hasResults: False
protocolSection identificationModule nctId: NCT06311422, orgStudyIdInfo id: CAD/CAM-endocrown, briefTitle: A 3-Year Clinical Evaluation Of Endocrown Restorations With Two Different Materials, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2020-03-15, primaryCompletionDateStruct date: 2023-03-15, completionDateStruct date: 2028-09-15, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Hacettepe University, class: OTHER, descriptionModule briefSummary: The clinical performance of two different materials in endodontically treated teeth produced with CAD/CAM system will be evaluated and compared. After obtaining a signed informed consert form from all the patients, all restorations will be placed by a single clinician. All endocrown restorations will be produced using the same CAD/CAM system. 52 restorations will be fabricated using Lava Ultimate (LU, 3M Espe, Seefeld, Germany) blocks and 38 restorations will be fabricated using Celtra Duo (CD, Dentsply Sirona, York, PA, USA) blocks. All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using modified United States Public Health Service (USPHS) criteria after baseline, 6,12,36, 48, 60 months. Descriptive statistics will be performed using Chi-square and Fisher exact test., conditionsModule conditions: Endodontically Treated Teeth, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 74, type: ACTUAL, armsInterventionsModule interventions name: resin nanoceramic block, interventions name: zirconia-reinforced lithium silicate, outcomesModule primaryOutcomes measure: Clinical performance of two materials, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Hacettepe University Faculty of Dentistry, city: Ankara, zip: 06060, country: Turkey, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06311409, orgStudyIdInfo id: SMFS2019, briefTitle: Validation Study of the Speedy Meyer Fall Scale for Determining the Fall Risk of the Paediatric Patient, statusModule overallStatus: RECRUITING, startDateStruct date: 2020-01-29, primaryCompletionDateStruct date: 2024-03, completionDateStruct date: 2024-04, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Meyer Children's Hospital IRCCS, class: OTHER, descriptionModule briefSummary: Fall prevention is an essential element in ensuring safe care for paediatric patients. The first step in building a risk reduction programme is the adoption of an assessment tool to identify those most at risk at an early stage. From October 2014 to date, a study has been conducted for the linguistic-cultural validation of the Humpty Dumpty Fall Scale (HDFS) in the Italian context, through a multicentre survey with the help of the Clinical Risk Management Group of the Region of Tuscany.The objective of this study is the validation of the new Humpty Dumpty Fall Scale defined as Speedy Meyer-Fall Scale (SMFS) by assessing the comprehension and validity of the scale and items via Content Validity Index (SCVI and ICVI) estimation of inter-item reliability (Crombach's alpha), inter-rater reliability (Cohen's K), sensitivity, specificity, PPV, NPV and ROC curve., conditionsModule conditions: Fall Prevention, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 332, type: ESTIMATED, outcomesModule primaryOutcomes measure: validation of the SMFS t, secondaryOutcomes measure: identification of patients high risk of falls, eligibilityModule sex: ALL, minimumAge: 1 Year, maximumAge: 16 Years, stdAges: CHILD, contactsLocationsModule locations facility: AUSL Toscana Sud Est, status: NOT_YET_RECRUITING, city: Arezzo, zip: 51100, country: Italy, geoPoint lat: 43.46276, lon: 11.88068, locations facility: Meyer Children's Hospital IRCCS, status: RECRUITING, city: Florence, country: Italy, contacts name: Daniele Ciofi, role: CONTACT, email: daniele.ciofi@meyer.it, geoPoint lat: 43.77925, lon: 11.24626, locations facility: Fondazione Gabriele monasterio - Ospedale Pediatrico Apuano Massa, status: NOT_YET_RECRUITING, city: Massa, country: Italy, geoPoint lat: 44.03541, lon: 10.13927, hasResults: False
protocolSection identificationModule nctId: NCT06311396, orgStudyIdInfo id: REVEAL, briefTitle: Development of a Neuronal Microscope, statusModule overallStatus: RECRUITING, startDateStruct date: 2021-01-01, primaryCompletionDateStruct date: 2024-01-01, completionDateStruct date: 2025-01-01, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, class: OTHER, descriptionModule briefSummary: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is a leading cause of cancer-related death worldwide. The prognosis of HCC remains poor, with a 5-year survival rate of 18%. Risk factors for HCC include viral infection, autoimmune hepatitis, chronic alcohol use or metabolic fatty liver disease, obesity, and diabetes mellitus., conditionsModule conditions: Hepatic Carcinoma, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: genetic model, outcomesModule primaryOutcomes measure: Isolation of epithelial cells, primaryOutcomes measure: Omics studies and functional morphological studies, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica, status: RECRUITING, city: Milan, state: Milano, zip: 20122, country: Italy, contacts name: Luca Vittorio Carlo Valenti, role: CONTACT, phone: 02 5503 6595, phoneExt: 56595, email: luca.valenti@policlinico.mi.it, geoPoint lat: 45.46427, lon: 9.18951, documentSection largeDocumentModule largeDocs typeAbbrev: Prot_SAP, hasProtocol: True, hasSap: True, hasIcf: False, label: Study Protocol and Statistical Analysis Plan, date: 2020-12-09, uploadDate: 2024-03-08T10:03, filename: Prot_SAP_000.pdf, size: 2182994, hasResults: False
protocolSection identificationModule nctId: NCT06311370, orgStudyIdInfo id: 2023-0100, briefTitle: Acceptability, Feasibility, and Development of an AI Driven, Multi-sensor, Non-invasive Digital Mental Health Platform in Children With ADHD and Emotional Symptoms, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-08-09, primaryCompletionDateStruct date: 2024-02-05, completionDateStruct date: 2024-02-05, studyFirstPostDateStruct date: 2024-03-15, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: MaxisHealth, class: INDUSTRY, descriptionModule briefSummary: This is an observational study collecting data using a wearable to measure the biometric features in youth with Attention deficit hyperactivity disorder(ADHD) and Autism., conditionsModule conditions: ADHD, conditions: Autism, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 10, type: ACTUAL, armsInterventionsModule interventions name: Observation, outcomesModule primaryOutcomes measure: Emotion dysregulation, eligibilityModule sex: ALL, minimumAge: 4 Years, maximumAge: 7 Years, stdAges: CHILD, contactsLocationsModule locations facility: The League School, city: Brooklyn, state: New York, zip: 11203, country: United States, geoPoint lat: 40.6501, lon: -73.94958, hasResults: False